Sunshine Biopharma Inc (SBFM)

[TraderAI]

Years later not much has changed except adva was finally put to rest. I'm sure it'll be reincarnated somehow. Wait..

K1.1 also kills cancer! Same types, pancreatic, multi resistant breast cells, etc...

Where's the update with this leading LNP partner or will that be in the next quarterly, too?


"Sunshine Biopharma’s mRNA-based anticancer macromolecule, is called K1.1.

The Company’s collaboration partner will prepare two LNP formulations (K1.1a and K1.1b) of Sunshine Biopharma’s in-house developed antineoplastic mRNA, K1.1. Sunshine Biopharma had previously shown that its K1.1 mRNA is capable of destroying cancer cells in vitro, including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). Parallel studies using normal human cells (HMEC) showed that K1.1 mRNA had little or no cytotoxic effects.

This is hilarious, someone posted on stocktwits

came across this interview article from 2011. Ceo stated human trial to start 12-18 month. Been saying the same shit over 10 years now. What’s changed? Money($42mil)? Lets stop lying to ourselves. Can’t even get pass preclinical. ?


https://www.ceocfointerviews.com/CEOCFO-Members/SBFM-SunshineBio114.htm
"